Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

Published:2011-05-25 Issue:1 Volume:11 Page:
ISSN:1471-2377
Container-title:BMC Neurology
language:en
Short-container-title:BMC Neurol

Author:

Farlow Martin,Veloso Felix,Moline Margaret,Yardley Jane,Brand-Schieber Elimor,Bibbiani Francesco,Zou Heng,Hsu Timothy,Satlin Andrew

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2377-11-57.pdf

Reference13 articles.

1. Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A: Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: a 24-week, randomized, double-blind study. Clin Ther. 2010, 32 (7): 1234-1251. 10.1016/j.clinthera.2010.06.019.

2. Rosler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal Bianco P, Stähelin HB, Hartman R, Gharabawi M, on behalf of the B303 Exelon Study Group: Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial [published erratum appears in: BMJ. 2001;322:1456]. BMJ. 1999, 318 (7184): 633-638.

3. Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG: Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry. 2004, 19 (7): 624-633. 10.1002/gps.1133.

4. Inglis F: The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl. 2002, 127: 45-63.

5. Farlow MR, Alva G, Meng X, Olin JT: A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis. Curr Med Res Opin. 2010, 26 (2): 263-269. 10.1185/03007990903434914.

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication of Hybrid Coated Microneedles with Donepezil Utilizing Digital Light Processing and Semisolid Extrusion Printing for the Management of Alzheimer’s Disease;Molecular Pharmaceutics;2024-08-20

2. The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer’s disease: a critical review;Expert Review of Neurotherapeutics;2024-05-24

3. Anti-dementia drugs: what is the evidence in advanced stages?;Porto Biomedical Journal;2024-03

4. Cognitive Enhancers and Treatments for Alzheimer’s Disease;Tasman’s Psychiatry;2024

5. Molecular docking study on acetylcholinesterase and urease enzyme inhibition effects of Amygdalin;Turkish Journal of Analytical Chemistry;2023-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3